Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion

Product Information *

• Company:

  GlaxoSmithKline (Ireland) Ltd

• Status:

  No Recent Update

• Active Ingredients :

  Belimumab

  This medicinal product is subject to additional monitoring.

  *Additional information is available upon request

• Legal Category:

  Product subject to medical prescription which may not be renewed (A)